This activity is intended for internal CCAD Physicians

Activity Description:

This activity is based on the American College of Surgeons, Commission on Cancer standards. To meet the Commission on Cancer (CoC) standards for multidisciplinary cancer case conferences aka tumor boards cancer programs hold multidisciplinary cancer case conference(s) to evaluate patient management.

Target Audience: 

Hematology/Oncology, Nursing, Pathology, Pharmacology, Radiology

Learning Objectives:

• Apply current evidence-based guidelines to the multidisciplinary management of Malignant Hematology across all stages of disease. 
• Interpret imaging, pathology, and genomic testing results to accurately stage disease and guide individualized treatment planning. 
• Integrate surgical, medical oncology, and radiation oncology perspectives to develop coordinated, patient-centered care plans.
• Identify appropriate candidates for systemic therapies, surgical interventions, and radiation strategies based on tumor biology and patient factors.
• Enhance communication and collaboration among multidisciplinary team members to reduce practice variability and improve quality of care.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). 

Cleveland Clinic Abu Dhabi is accredited by the ACCME to provide continuing medical education for physicians.

Each session of this activity is designated for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosure:

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Abu Dhabi requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they have no relationships which, in the context of their presentation, could be perceived as a potential conflict of interest:

Activity Director: Ajlan Al Zaki, MD